Defective apoptotic cell clearance in asthma and COPD: a new drug target for statins?

Research output: Contribution to journalArticlepeer-review

29 Citations (Scopus)


Asthma and chronic obstructive pulmonary disease represent increasingly common respiratory conditions with a clear unmet need for more effective and safer therapy. Airway inflammation is key to both asthma pathogenesis and exacerbations of symptoms in chronic obstructive pulmonary disease. Several lines of evidence are now emerging implicating the increased persistence of apoptotic cells in patients with chronic inflammatory lung diseases and that this is largely due to a combination of inhibition of, or defects in, the apoptotic process and/or impaired apoptotic cell removal mechanisms.
Original languageEnglish
Pages (from-to)6-11
Number of pages6
JournalTrends in Pharmacological Sciences
Issue number1
Early online date4 Dec 2007
Publication statusPublished - Jan 2008


  • Anti-Asthmatic Agents
  • Apoptosis
  • Asthma
  • Drug Delivery Systems
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Pulmonary Disease, Chronic Obstructive


Dive into the research topics of 'Defective apoptotic cell clearance in asthma and COPD: a new drug target for statins?'. Together they form a unique fingerprint.

Cite this